India Defends Its Pharmaceutical Industry After Tainted Drug Scandal
India on Monday defended its lucrative and booming generic drugs industry as “safe” and “highly regulated”, after the country’s largest drug maker Ranbaxy pleaded guilty last month to U.S. criminal charges of making adulterated medicines.
In a bid to defend its generic drugs export sector, the Indian government also suggested that “vested interests” may be making up the “isolated reports” of spurious generic drugs found in global markets allegedly from India.